{"filing":{"accession_number":"0001628280-26-053285","cik":"0001666071","ticker":"CDLX","company_name":"Cardlytics, Inc.","form":"8-K","filing_date":"2026-08-05","report_date":"2026-08-05","primary_document":"cdlx-20260805.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1666071/000162828026053285/cdlx-20260805.htm"},"events":[{"id":24950,"run_id":22620,"accession_number":"0001628280-26-053285","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"summary":"This is a standard earnings release disclosing Cardlytics' financial results for Q2 2026 (three and six months ended June 30, 2026), including revenues of $36.9 million, net loss of $(14.9) million, and forward guidance for Q3 2026. The press release is furnished as Exhibit 99.1 and filed under Item 2.02, which is the standard Item for earnings announcements. Material to investors as it provides quarterly operating results and management guidance.","company_name":"Cardlytics, Inc.","ticker":"CDLX","filing_date":"2026-08-05","form":"8-K","submitted_at":null,"items":[{"id":25659,"accession_number":"0001628280-26-053285","item_number":"2.02","item_title":"RESULTS OF OPERATIONS AND FINANCIAL CONDITION","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"This is a standard earnings release disclosing Cardlytics' financial results for Q2 2026 (three and six months ended June 30, 2026), including revenues of $36.9 million, net loss of $(14.9) million, and forward guidance for Q3 2026. The press release is furnished as Exhibit 99.1 and filed under Item 2.02, which is the standard Item for earnings announcements. Material to investors as it provides quarterly operating results and management guidance.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-07T02:37:59.790286+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":25659,"accession_number":"0001628280-26-053285","item_number":"2.02","item_title":"RESULTS OF OPERATIONS AND FINANCIAL CONDITION","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"This is a standard earnings release disclosing Cardlytics' financial results for Q2 2026 (three and six months ended June 30, 2026), including revenues of $36.9 million, net loss of $(14.9) million, and forward guidance for Q3 2026. The press release is furnished as Exhibit 99.1 and filed under Item 2.02, which is the standard Item for earnings announcements. Material to investors as it provides quarterly operating results and management guidance.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-07T02:37:59.790286+00:00","company_name":"Cardlytics, Inc.","ticker":"CDLX","filing_date":"2026-08-05"}]}